Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gemphire Therapeutics Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gemphire Therapeutics Inc. since year 2005.
Table 2 shows the detailed insider transactions of Gemphire Therapeutics Inc. since 2005.
The reporting company's ticker symbol is GEMP. The reporting company's CIK number is 1638287.
The total value of stock buying since 2005 is $7,730,438.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $28,296.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-02-08||Reno Seth (Chief Commercial Officer)||Buy||14,286||7.00||100,002|
|2017-08-14||Mathiesen Jeffrey S (Chief Financial Officer)||Option Ex||3,207||3.59||11,513|
|2017-08-10||Mathiesen Jeffrey S (Chief Financial Officer)||Option Ex||3,000||3.59||10,770|
|2017-07-31||Bisgaier Charles Phd (Chief Scientific Off. & Chair)||Option Ex||4,474||1.34||6,013|
|2017-03-10||Hawryluk P. Kent (Director)||Buy||25,000||9.47||236,750|
|2017-03-10||Gullans Steven R. Ph.d. (Director)||Buy||52,798||9.47||499,997|
|2017-03-10||Sassine Andy (Director)||Buy||21,119||9.47||199,996|
|2017-03-10||Lichtinger Pedro (Director)||Buy||10,559||9.47||99,993|
|2016-08-10||Lowenschuss David (Chief Legal Off. & Secretary)||Buy||11,120||10.00||111,200|
|2016-08-10||Sooch Mina (President & CEO)||Buy||52,500||10.00||525,000|
|2016-08-10||Reno Seth (Chief Commercial Officer)||Buy||4,000||10.00||40,000|
|2016-08-10||Hawryluk P. Kent (Director)||Buy||25,000||10.00||250,000|
|2016-08-10||Gullans Steven R. Ph.d. (Director)||Buy||500,000||10.00||5,000,000|
|2016-08-10||Lichtinger Pedro (Director)||Buy||10,000||10.00||100,000|
|2016-08-10||Bisgaier Charles Phd (Chair & Chief Scientific Off.)||Buy||51,750||10.00||517,500|
|2016-08-10||Mathiesen Jeffrey S (Chief Financial Officer)||Buy||4,000||10.00||40,000|
|2016-08-10||Kousky Kenneth W (Director)||Buy||1,000||10.00||10,000|
Insider trading activities including stock purchases, stock sales, and option exercises of GEMP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gemphire Therapeutics Inc. (symbol GEMP, CIK number 1638287) see the Securities and Exchange Commission (SEC) website.